Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic loperamide for abemaciclib-induced diarrhea in breast cancer
jRCT1041240134Recruiting
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of loperamide in breast cancer. Started Dec 2024; status: recruiting.
02
Drugs
loperamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT1041240134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041240134.